CHOP-like Regimen in Combination with Rituximab and Peginterferon Alpha-2b in Newly-diagnosed Diffuse Large B-cell Non-Hodgkin’s Lymphoma: Experience in a Chinese Center

CHOP-like Regimen in Combination with Rituximab and Peginterferon Alpha-2b in Newly-diagnosed Diffuse Large B-cell Non-Hodgkin’s Lymphoma: Experience in a Chinese Center

OBJECTIVE To evaluate the efficacy of rituximab combined with CHOP-like regimen with or without IFN in patients newly diagnosed diffuse large B-cell Non-Hodgkin’s lymphoma (DLBCL). METHODS From January 2003 to July 2008, 51 patients received CHOP-like chemotherapy (cyclophosphamide 750 mg/m2,...

Full description

Bibliographic Details
Main Author: Shu-qing LV, Jian-min YANG, Xian-min SONG, Li CHEN, Wei-ping ZHANG, Xiao-qian XU, Xiong NI, Chong-mei HUANG, Yi HE, Jian-min WANG
Format: Article
Language:English
Published: China Anti-Cancer Association 2010-04-01
Series:Cancer Biology & Medicine
Subjects:
CHOP-like
rituximab
peginterferon alpha-2b
non-Hodgkin’s lymphoma
diff use large B-cell.
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/139

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/139

Similar Items